Ethical choreography in China's Human Gene Editing controversy

被引:1
作者
Au, Larry [1 ]
机构
[1] CUNY City Coll, Dept Sociol, New York, NY 10031 USA
关键词
CRISPR; gene-editing; China; scientific controversy; ethical choreography; boundary work; BOUNDARY-WORK; SCIENCE; INNOVATION; MEDICINE; POLITICS; BIOTECH; STIGMA; BENCH; STATE; LIFE;
D O I
10.1080/09505431.2023.2218401
中图分类号
G [文化、科学、教育、体育]; C [社会科学总论];
学科分类号
03 ; 0303 ; 04 ;
摘要
He Jiankui announced to the world in November 2018 that his team had genetically edited twin human embryos that were then brought to term. Recruiting participants through an HIV outreach group and using CRISPR/Cas9 technology, He targeted the CCR5 genes claiming this would make the children immune to HIV. One way to understand He's case is through Charis Thompson's concept of ethical choreography, which shows how scientists 'invent around' potential ethical objections to their work. In particular, such a focus on ethical choreography traces how individual scientists can exploit ambiguity in institutional boundaries to recombine different logics to advance their vision of good, innovative, and ethical science. He's actions can be seen to been the result of his traversal of blurred boundaries that demarcate science/market and science/medicine in order to recombine academic, market, medical, and cultural logics. This combination of logics is seen in ethical justifications that He put forth for his experiment, which provoked much criticism and controversy, but should nonetheless be taken seriously and placed in context. While He's vision of good science was rejected, examples of ethical choreography can be found in other instances of biomedical innovation and there remains the potential for other scientists to pick up where He left off. Following the ethical choreography of scientists also allows for more specificity in discussions about what and when boundaries should be strengthened or relaxed in order to advance a more equitable vision of science and technology.
引用
收藏
页码:535 / 557
页数:23
相关论文
共 114 条
[1]   Spliced: Boundary-work and the establishment of human gene therapy [J].
Addison, Courtney .
BIOSOCIETIES, 2017, 12 (02) :257-281
[2]   Bench, bedside, boardroom: negotiating translational gene therapy [J].
Addison, Courtney .
NEW GENETICS AND SOCIETY, 2017, 36 (01) :22-42
[3]   Recent scientific/intellectual movements in biomedicine [J].
Au, Larry .
SOCIAL SCIENCE & MEDICINE, 2021, 278
[4]   Imagining the public: anticipatory discourses in China's push for precision medicine [J].
Au, Larry .
BIOSOCIETIES, 2022, 17 (01) :53-77
[5]   Globalizing the Scientific Bandwagon: Trajectories of Precision Medicine in China and Brazil [J].
Au, Larry ;
da Silva, Renan Goncalves Leonel .
SCIENCE TECHNOLOGY & HUMAN VALUES, 2021, 46 (01) :192-225
[6]  
Begley S., 2019, STAT BLOG 0417
[7]  
Begley S., 2018, STAT BLOG 1217
[8]  
Begley S., 2019, STAT BLOG 0529
[9]  
Belluck P., 2018, New York Times
[10]   Scientific misconduct at an elite medical institute: The role of competing institutional logics and fragmented control [J].
Berggren, Christian ;
Karabag, Solmaz Filiz .
RESEARCH POLICY, 2019, 48 (02) :428-443